← brief for 2026-10-09 · Nutrition & lifestyle

SGLT2 inhibitors and exercise in diabetic kidney disease: mechanistic rationale, emerging clinical evidence, and future perspectives

Key takeaways

This review looks at how sugar-blocking drugs and exercise work together for kidney disease. It summarizes what is known so far.

Who did this work

Huajuan Li (Cixian People's Hospital) · Min Ai (Cixian People's Hospital) · Xiangyu He (Southwest General Health Center) · Caijun Liu (Cixian People's Hospital) · Xuegui Ju (Chengdu Medical College)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-08
https://doi.org/10.3389/fmed.2026.1968588